Cizzle Biotechnology (LON:CIZ) Issues Earnings Results

Cizzle Biotechnology (LON:CIZ) issued its quarterly earnings results on Wednesday. The company reported GBX (0.08) EPS for the quarter, Digital Look Earnings reports.

Cizzle Biotechnology Trading Down 13.8%

Cizzle Biotechnology stock opened at GBX 1.47 on Wednesday. The firm has a market capitalization of £6.23 million, a P/E ratio of -8.62 and a beta of 0.02. Cizzle Biotechnology has a twelve month low of GBX 1.20 and a twelve month high of GBX 3.90. The stock’s fifty day simple moving average is GBX 1.67 and its 200-day simple moving average is GBX 2.23.

About Cizzle Biotechnology

Cizzle Biotechnology Holdings Plc, together with its subsidiaries, engages in the development of an immunoassay test for the CIZ1B biomarker for the early detection of lung cancer in the United Kingdom. The company was formerly known as Cizzle Biotechnology Limited and changed its name to Cizzle Biotechnology Holdings Plc in May 2021. Cizzle Biotechnology Holdings Plc is headquartered in London, the United Kingdom.